The in vitro pharmacological profile of prucalopride, a novel enterokinetic compound
- 27 June 2001
- journal article
- Published by Elsevier
- Vol. 423 (1) , 71-83
- https://doi.org/10.1016/s0014-2999(01)01087-1
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Mapping of serotonin 5-HT4 receptor mRNA and ligand binding sites in the post-mortem human brainSynapse, 2000
- Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humansGut, 1999
- Integrated modelling of the clinical pharmacokinetics of SDZ HTF 919, a novel selective 5‐HT4 receptor agonist, following oral and intravenous administrationBritish Journal of Clinical Pharmacology, 1999
- Effect of a novel prokinetic drug, R093877, on gastrointestinal transit in healthy volunteersGut, 1998
- Nonlinear regression using spreadsheetsTrends in Pharmacological Sciences, 1995
- Functional evidence for a 5‐HT2B receptor mediating contraction of longitudinal muscle in human small intestineBritish Journal of Pharmacology, 1995
- Further characterization of 5‐hydroxytryptamine receptors (putative 5‐HT2B) in rat stomach fundus longitudinal muscleBritish Journal of Pharmacology, 1994
- Pharmacological characterization of 5‐hydroxytryptamine receptor types in the guinea‐pig proximal colonNeurogastroenterology & Motility, 1993
- Combined dose‐ratio analysis of cholecystokinin receptor antagonists, devazepide, lorglumide and loxiglumide in the guinea‐pig gall bladderBritish Journal of Pharmacology, 1992
- Distribution of acetylcholinesterase and butyrylcholinesterase in the myenteric plexus and longitudinal muscle of the guinea-pig intestineBiochemical Pharmacology, 1971